Samantha Lien
35 works · 1,148 citations · h-index 11
Top works
- Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo
- Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
- Therapeutic peptides
- Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor-α Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
- Therapeutic Anti-VEGF Antibodies
- Establishing a Link Between Amino Acid Sequences and Self-Associating and Viscoelastic Behavior of Two Closely Related Monoclonal Antibodies
- A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life
- The polymorphic human glutathione transferase T1-1, the most efficient glutathione transferase in the denitrosation and inactivation of the anticancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea
- A Substrate-Phage Approach for Investigating Caspase Specificity
- Linkers for improved cleavage of fusion proteins with an engineered α‐lytic protease
- Human Glutathione Transferase A1-1 Demonstrates Both Half-of-the-sites and All-of-the-sites Reactivity
- Combinatorial Strategies for the Discovery of Novel Protease Specificities
- Multiple Novel Classes of APRIL-specific Receptor-blocking Peptides Isolated by Phage Display
- Isolating Substrates for an Engineered α-Lytic Protease by Phage Display
- Erratum to: Isolating Substrates for an Engineered α-lytic Protease by Phage Display
- Improved production of peptides from fusion proteins / by Samantha Lien.
- Supplementary Figure 6 from A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life
- Data from A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life
- Data from A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life
- Supplementary Figure 4 from A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life